Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

JOURNAL FOR IMMUNOTHERAPY OF CANCER

Correale, P; Saladino, RE; Giannarelli, D; Giannicola, R; Agostino, R; Staropoli, N; Strangio, A; Del Giudice, T; Nardone, V; Altomonte, M; Pastina, P; Tini, P; Falzea, AC; Imbesi, N; Arcati, V; Romeo, G; Caracciolo, D; Luce, A; Caraglia, M; Giordano, A; Pirtoli, L; Necas, A; Amler, E; Barbieri, V; Tassone, P; Tagliaferri, P, 2020: Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade. JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(1), doi: 10.1136/jitc-2020-000733

Research Groups:

• Orthopaedics and Surgery - Pavel Proks

CEITEC authors:

• Prof. Alois Nečas, Ph.D.